Literature DB >> 2159632

Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.

U H Mortensen1, T Stevnsner, S Krogh, K Olesen, O Westergaard, B J Bonven.   

Abstract

Inhibition of eukaryotic DNA topoisomerase I by the minor groove binding ligand, distamycin A, was investigated. Low concentrations of the ligand selectively prevented catalytic action at a high affinity topoisomerase I binding sequence. A restriction enzyme protection assay indicated that the catalytic cycle was blocked at the binding step. Distamycin binding sites on DNA were localized by hydroxyl radical footprinting. A strongly preferred site mapped to a homopolymeric (dA).(dT)-tract partially included in the essential topoisomerase I binding region. Mutational elimination of the stable helix curvature associated with this ligand binding site demonstrated that (i) the intrinsic bend was unessential for efficient binding of topoisomerase I, and (ii) distamycin inhibition did not occur by deformation of a stable band. Alternative modes of inhibition are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159632      PMCID: PMC330672          DOI: 10.1093/nar/18.8.1983

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Sequence-specific recognition of double helical nucleic acids by proteins.

Authors:  N C Seeman; J M Rosenberg; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

2.  Interactions between eukaryotic DNA topoisomerase I and a specific binding sequence.

Authors:  T Stevnsner; U H Mortensen; O Westergaard; B J Bonven
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

3.  In vitro preferential topoisomerization of bent DNA.

Authors:  M Caserta; A Amadei; E Di Mauro; G Camilloni
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

4.  Effect of minor groove binding drugs on mammalian topoisomerase I activity.

Authors:  M M McHugh; J M Woynarowski; R D Sigmund; T A Beerman
Journal:  Biochem Pharmacol       Date:  1989-07-15       Impact factor: 5.858

5.  Transmission of allosteric effects in DNA.

Authors:  M Hogan; N Dattagupta; D M Crothers
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

6.  Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA.

Authors:  K A Edwards; B D Halligan; J L Davis; N L Nivera; L F Liu
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

7.  Rapid purification and characterization of DNA topoisomerase I from cultured mouse mammary carcinoma FM3A cells.

Authors:  K Ishii; T Hasegawa; K Fujisawa; T Andoh
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

8.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  Map of distamycin, netropsin, and actinomycin binding sites on heterogeneous DNA: DNA cleavage-inhibition patterns with methidiumpropyl-EDTA.Fe(II).

Authors:  M W Van Dyke; R P Hertzberg; P B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements.

Authors:  M Broggini; M Ponti; S Ottolenghi; M D'Incalci; N Mongelli; R Mantovani
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

View more
  4 in total

1.  Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.

Authors:  A Bell; L Kittler; G Löber; C Zimmer
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

2.  Specific inhibition of human DNA ligase adenylation by a distamycin derivative possessing antitumor activity.

Authors:  A Montecucco; M Fontana; F Focher; M Lestingi; S Spadari; G Ciarrocchi
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

3.  Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.

Authors:  M Bellorini; V Moncollin; M D'Incalci; N Mongelli; R Mantovani
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

4.  Distamycin-induced inhibition of homeodomain-DNA complexes.

Authors:  A Dorn; M Affolter; M Müller; W J Gehring; W Leupin
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.